InvestorsHub Logo
Followers 34
Posts 3558
Boards Moderated 0
Alias Born 11/17/2013

Re: Ready4Nxt post# 539355

Sunday, 11/27/2022 5:46:39 PM

Sunday, November 27, 2022 5:46:39 PM

Post# of 704378
This is NOT a positive story. It is a soft bash. It leads with "People who got the treatment had double the average survival rate — but the results aren’t as clear as they seem."
Then it continues to quote Donald O’Rourke, a professor of neurosurgery who was in the STAT hit piece by AF with his false conclusion. then it quotes Merit Cudkowicz, the chief of neurology that this was a "post hoc analysis." Finally it concludes that : "To find out, though, Northwest Bio will need more trials, designed in such a way that the results are indisputable.

This is definitely a soft bash - not at all a good article about DCVAX.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News